Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA(2)DS(2)-VASc Score 0–1: A Korean Multi-Center Cohort

PURPOSE: Atrial fibrillation (AF) patients with low to intermediate risk, defined as non-gender CHA(2)DS(2)-VASc score of 0–1, are still at risk of stroke. This study verified the usefulness of ABCD score [age (≥60 years), B-type natriuretic peptide (BNP) or N-terminal pro-BNP (≥300 pg/mL), creatini...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Moonki, Byeon, Kyeongmin, Kang, Ki-Woon, Park, Yae Min, Hwang, You Mi, Lee, Sung Ho, Jin, Eun-Sun, Roh, Seung-Young, Kim, Jin Seok, Ahn, Jinhee, Lee, So-Ryoung, Choi, Eue-Keun, Ahn, Min-soo, Lee, Eun Mi, Park, Hwan-Cheol, Lee, Ki Hong, Kim, Min, Choi, Joon Hyouk, Ko, Jum Suk, Kim, Jin Bae, Kim, Changsoo, Lip, Gregory Y.H., Shin, Seung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520051/
https://www.ncbi.nlm.nih.gov/pubmed/36168241
http://dx.doi.org/10.3349/ymj.2022.0157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520051/
https://www.ncbi.nlm.nih.gov/pubmed/36168241
http://dx.doi.org/10.3349/ymj.2022.0157

Ejemplares similares